Pilling Wecksorb Neurosponges Recall Due to Endotoxin Levels
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Teleflex LLC recalls 1,488,700 units of Pilling Wecksorb Neurosponges due to out-of-specification endotoxin levels.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on August 6, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, MedicalDevices.
What Happened
Teleflex LLC is conducting a voluntary recall of Pilling Wecksorb Neurosponges because of out-of-specification, or potential out-of-specification, levels of endotoxins.
Which Products Are Affected
The recall affects Pilling Wecksorb Neurosponges (Cotton) and Pilling Wecksorb Neurosponge Strips (Cotton) with catalog numbers 200100, 200101, 200102, 200103, 200104, 200105, 200106, 200108, 200110, 200112, 200120, 200121, 200123, and 200131. A total of 1,488,700 units distributed worldwide, including U.S. nationwide (AK, AL, AR, AZ, CA, CO, CT, FL, GA, HI, IA, ID, IL, IN, KS, KY, MA, MD, ME, MI, MN, MO, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, WA, WI, WV) and Panama. Specific UDI codes and lot/batch numbers are detailed in FDA recall Z-2639-2026.
What You Should Do
No specific consumer action steps are provided in the recall notice.
Why This Matters
The affected neurosponges are used to protect brain and central nervous system tissue during cranial and spine surgery.
Source
FDA Enforcement Report, recall number Z-2639-2026 (https://www.fda.gov)
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,127 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to August 6, 2026.
Frequently Asked Questions
Common questions about this FDA recall.